Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

RemeGen completes phase II study of telitacicept in IgAN

Aug. 12, 2021

Goldfinch Bio initiates dosing in extension study of GFB-887 for patients with FSGS

Aug. 11, 2021

Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346

Aug. 10, 2021

Phase I data with ANG-3070 pave way for phase II study in primary proteinuric kidney diseases

Aug. 3, 2021

CIHR grant supports Arch's evaluation of LSALT in chronic kidney and lung diseases

July 15, 2021

Chinese investigators divulge P2X3 receptor antagonists

July 6, 2021

DiaMedica reports interim phase II data on DM-199 in chronic kidney disease

June 29, 2021

FDA clears IND for clinical evaluation of CLBS-201 for diabetic kidney disease

June 23, 2021

Shijiazhuang Yiling Pharmaceutical identifies HIPK2 inhibitors

June 14, 2021

Iptacopan safely and effectively stabilizes eGFR in patients with C3 glomerulopathy

June 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...